“Yes. If the vendors can leverage the size and purchasing power of the Medicare program to reduce the cost from the manufacturer, then both the vendor and the patients can obtain better pricing.”
Meaning what? Price caps? How does that obtain “better pricing” for the vendor when they are forced to sell it below the market value?
The drug companies do not sell the drugs directly to the patients. They sell them to vendors. The vendors who have the contracts for Medicare can their use their size to negotiate better prices from the manufacturers and pass some of the savings along to the patients. This is negotiation and not price caps.